CLVLY
Price
$7.55
Change
-$0.45 (-5.62%)
Updated
Dec 18 closing price
QLGN
Price
$4.09
Change
-$0.14 (-3.31%)
Updated
Dec 18, 03:56 PM (EDT)
Ad is loading...

CLVLY vs QLGN

Header iconCLVLY vs QLGN Comparison
Open Charts CLVLY vs QLGNBanner chart's image
Clinuvel Pharmaceuticals
Price$7.55
Change-$0.45 (-5.62%)
Volume$1.01K
CapitalizationN/A
Qualigen Therapeutics
Price$4.09
Change-$0.14 (-3.31%)
Volume$3.22K
CapitalizationN/A
CLVLY vs QLGN Comparison Chart
Loading...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLVLY vs. QLGN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLY is a Hold and QLGN is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CLVLY: $8.00 vs. QLGN: $4.23)
Brand notoriety: CLVLY and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLY: 28% vs. QLGN: 8%
Market capitalization -- CLVLY: $380.78M vs. QLGN: $2.87M
CLVLY [@Biotechnology] is valued at $380.78M. QLGN’s [@Biotechnology] market capitalization is $2.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLY’s FA Score shows that 1 FA rating(s) are green whileQLGN’s FA Score has 1 green FA rating(s).

  • CLVLY’s FA Score: 1 green, 4 red.
  • QLGN’s FA Score: 1 green, 4 red.
According to our system of comparison, QLGN is a better buy in the long-term than CLVLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QLGN’s TA Score shows that 5 TA indicator(s) are bullish.

  • QLGN’s TA Score: 5 bullish, 3 bearish.

Price Growth

CLVLY (@Biotechnology) experienced а -1.48% price change this week, while QLGN (@Biotechnology) price change was -1.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

QLGN is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLY($381M) has a higher market cap than QLGN($2.87M). CLVLY has higher P/E ratio than QLGN: CLVLY (17.06) vs QLGN (0.00). CLVLY YTD gains are higher at: -27.373 vs. QLGN (-84.618).
CLVLYQLGNCLVLY / QLGN
Capitalization381M2.87M13,266%
EBITDAN/AN/A-
Gain YTD-27.373-84.61832%
P/E Ratio17.060.001,590,371%
RevenueN/AN/A-
Total CashN/A119K-
Total DebtN/A1.67M-
FUNDAMENTALS RATINGS
CLVLY vs QLGN: Fundamental Ratings
CLVLY
QLGN
OUTLOOK RATING
1..100
6771
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
39100
PRICE GROWTH RATING
1..100
8265
P/E GROWTH RATING
1..100
9239
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLY's Valuation (2) in the null industry is in the same range as QLGN (28). This means that CLVLY’s stock grew similarly to QLGN’s over the last 12 months.

CLVLY's Profit vs Risk Rating (100) in the null industry is in the same range as QLGN (100). This means that CLVLY’s stock grew similarly to QLGN’s over the last 12 months.

CLVLY's SMR Rating (39) in the null industry is somewhat better than the same rating for QLGN (100). This means that CLVLY’s stock grew somewhat faster than QLGN’s over the last 12 months.

QLGN's Price Growth Rating (65) in the null industry is in the same range as CLVLY (82). This means that QLGN’s stock grew similarly to CLVLY’s over the last 12 months.

QLGN's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for CLVLY (92). This means that QLGN’s stock grew somewhat faster than CLVLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QLGN
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CLVLY and

Correlation & Price change

A.I.dvisor tells us that CLVLY and BMNDF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and BMNDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLY
1D Price
Change %
CLVLY100%
+0.60%
BMNDF - CLVLY
26%
Poorly correlated
N/A
TPIA - CLVLY
23%
Poorly correlated
N/A
QLGN - CLVLY
21%
Poorly correlated
-3.64%
EXAI - CLVLY
21%
Poorly correlated
N/A
ZLAB - CLVLY
21%
Poorly correlated
+3.02%
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with BNOX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then BNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-3.64%
BNOX - QLGN
61%
Loosely correlated
-4.24%
ZLDAF - QLGN
34%
Loosely correlated
N/A
TIL - QLGN
31%
Poorly correlated
-3.60%
MRNS - QLGN
31%
Poorly correlated
-0.28%
ZVSA - QLGN
28%
Poorly correlated
-2.43%
More